ArticleEuropean urology open science2021

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.

Karen A Autio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.